Search

Your search keyword '"Papazoglou, Dimitrios"' showing total 362 results
Start Over Author "Papazoglou, Dimitrios"
362 results on '"Papazoglou, Dimitrios"'

1. High-energy polarized electron beams from the ionization of isolated spin polarized hydrogen atoms

Author

Sofikitis, Dimitris, Stamatakis, Marios G., Papazoglou, Dimitrios G., and Rakitzis, T. Peter

Subjects
Physics - Atomic Physics, Physics - Accelerator Physics, Physics - Chemical Physics, Physics - Plasma Physics
Abstract

We propose a laser-based method for the preparation of high-energy, highly-polarized electrons, from the ionization of isolated spin-polarized hydrogen (SPH) atoms. The SPH atoms are prepared from the photodissociation of HBr, using two consecutive shaped UV pulses of ps duration. By appropriately timing and focusing the pulses, we can spatially separate the highly polarized SPH from other unwanted photoproducts, which then act as the target for the ion-acceleration lasers. The density of SPH can surpass $\approx$10$^{18}$ cm$^{-3}$, allowing the production of GeV electrons with polarization larger than 90%.

Published
2024

3. Knowledge and perceptions about COVID-19 among health care workers: Evidence from COVID-19 hospitals during the second pandemic wave

Author

Ioannou, Petros, Karakonstantis, Stamatis, Mathioudaki, Anna, Sourris, Angelos, Papakosta, Vasiliki, Panagopoulos, Periklis, Petrakis, Vasilis, Papazoglou, Dimitrios, Arvaniti, Kostoula, Trakatelli, Christina Maria, Christodoulou, Evgenia, Poulakou, Garyfallia, Syrigos, Konstantinos N, Rapti, Vasiliki, Leontis, Konstantinos, Karapiperis, Dimitrios, and Kofteridis, Diamantis P

Published
2021

6. Elective Surgical Repair of Popliteal Artery Aneurysms with Posterior Approach vs. Endovascular Exclusion: Early and Long Term Outcomes of Multicentre PARADE Study

Author

Adami, Daniele, Andreini, Marco, Scarati, Valentina, Pulli, Raffaele, Pratesi, Carlo, Fargion, Aaron Thomas, Biancofiore, Brigida, Grego, Franco, Squizzato, Francesco, Piazza, Michele, Colacchio, Elda Chiara, Ruffino, Maria Antonella, Robaldo, Alessandro, Bertoglio, Luca, Baggi, Paolo, Verrengia, Apollonia, Ippoliti, Arnaldo, Oddi, Fabio Massimo, Ascoli Marchetti, Andrea, Di Marzo, Luca, Mansour, Wassim, Di Girolamo, Alessia, Marzano, Antonio, Kotelis, Drosos, Zielasek, Christian, Papazoglou, Dimitrios D., Perkmann, Reinhold, Pipitone, Marco D., Taurino, Maurizio, Sirignano, Pasqualino, Romano, Elisa, Lenti, Massimo, Isernia, Giacomo, Simonte, Gioele, Fino, Gianluigi, Veraldi, Gian F., Mezzetto, Luca, Angiletta, Domenico, Zacà, Sergio, Ringold, Margot, Sodero, Francesca, Pitoulias, Georgios, Chatzelas, Dimitrios A., Traina, Luca, Zenunaj, Gladiol, Khashram, Manar, Ghamri, Nusr, Lovelock, Thomas M., D’Elia, Marcello, Hamdy, Ayman, Biasi, Lukla, Sanjay, Patel, Lepidi, Sandro, D’Oria, Mario, Badalamenti, Giovanni, Ruggiero, Massimo G., Desantis, Claudio, Filippi, Federico, Anzaldi, Manfredi, Siani, Andrea, Accrocca, Federico, Gabrielli, Roberto, Bartoli, Stefano, Martelli, Massimiliano, Micheli, Raimondo, Gugliotta, Maria C., Besias, Nikolaos, Roditis, Konstantinos, Usai, Marco V., Tshomba, Yamume, Natola, Marco, Scurto, Lucia, Korosoglou, Grigorios, Schoefthaler, Christoph, Jehn, Amila, Davies, Robert, Maritati, Gabriele, Ghosh, Shantonu Kumar, Donas, Konstantinos P., Pitoulias, Apostolos G., Avranas, Konstantinos, Bafile, Gennaro, Martelli, Eugenio, Cavallo, Eduardo, Caronno, Roberto, Alberti, Aldo, Volpe, Pietro, Massara, Mafalda, Alberti, Antonino, Zappadu, Sara, Troisi, Nicola, Bertagna, Giulia, Saratzis, Athanasios, Zayed, Hany, Torsello, Giovanni B., Dorigo, Walter, Antonello, Michele, Prouse, Giorgio, Bonardelli, Stefano, and Berchiolli, Raffaella

Published
2024
Full Text
View/download PDF

9. Mitochondrial Fraction of Circulating Cell-Free DNA as an Indicator of Human Pathology

Author

Panagopoulou, Maria, primary, Karaglani, Makrina, additional, Tzitzikou, Konstantina, additional, Kessari, Nikoleta, additional, Arvanitidis, Konstantinos, additional, Amarantidis, Kyriakos, additional, Drosos, George I., additional, Gerou, Spyros, additional, Papanas, Nikolaos, additional, Papazoglou, Dimitrios, additional, Baritaki, Stavroula, additional, Constantinidis, Theodoros C., additional, and Chatzaki, Ekaterini, additional

Published
2024
Full Text
View/download PDF

23. Overtreatment and associated risk factors among multimorbid older patients with diabetes

Author

Baretella, Oliver, primary, Alwan, Heba, additional, Feller, Martin, additional, Aubert, Carole E., additional, Del Giovane, Cinzia, additional, Papazoglou, Dimitrios, additional, Christiaens, Antoine, additional, Meinders, Arend‐Jan, additional, Byrne, Stephen, additional, Kearney, Patricia M., additional, O'Mahony, Denis, additional, Knol, Wilma, additional, Boland, Benoît, additional, Gencer, Baris, additional, Aujesky, Drahomir, additional, and Rodondi, Nicolas, additional

Published
2023
Full Text
View/download PDF

26. Enzalutamide in Patients With Castration-Resistant Prostate Cancer Progressing After Docetaxel: Retrospective Analysis of the Swiss Enzalutamide Named Patient Program

Author

Papazoglou, Dimitrios, Wannesson, Luciano, Berthold, Dominik, Cathomas, Richard, Gillessen, Silke, Rothermundt, Christian, Hasler, Loretta, Winterhalder, Ralph, Barth, Andreas, Mingrone, Walter, Nussbaum, Catrina Uhlmann, von Rohr, Lukas, von Burg, Philippe, Schmid, Mathias, Richner, Jürg, Baumann, Sylvia, Kühne, Reto, Stenner, Frank, and Rothschild, Sacha I.

Published
2017
Full Text
View/download PDF

27. Overtreatment and associated risk factors among multimorbid older patients with diabetes

Author

Baretella, Oliver, Alwan, Heba, Feller, Martin, Aubert, Carole E, Del Giovane, Cinzia, Papazoglou, Dimitrios, Christiaens, Antoine, Meinders, Arend-Jan, Byrne, Stephen, Kearney, Patricia M, O'Mahony, Denis, Knol, Wilma, Boland, Benoît, Gencer, Baris, Aujesky, Drahomir, and Rodondi, Nicolas

Subjects
360 Social problems & social services, 610 Medicine & health
Abstract

BACKGROUND In multimorbid older patients with type 2 diabetes mellitus (T2DM), the intensity of glucose-lowering medication (GLM) should be focused on attaining a suitable level of glycated hemoglobin (HbA1c ) while avoiding side effects. We aimed at identifying patients with overtreatment of T2DM as well as associated risk factors. METHODS In a secondary analysis of a multicenter study of multimorbid older patients, we evaluated HbA1c levels among patients with T2DM. Patients were aged ≥70 years, with multimorbidity (≥3 chronic diagnoses) and polypharmacy (≥5 chronic medications), enrolled in four university medical centers across Europe (Belgium, Ireland, Netherlands, and Switzerland). We defined overtreatment as HbA1c

Published
2023

30. Overtreatment and associated risk factors among multimorbid older patients with diabetes

Author

MS Geriatrie, Baretella, Oliver, Alwan, Heba, Feller, Martin, Aubert, Carole E, Del Giovane, Cinzia, Papazoglou, Dimitrios, Christiaens, Antoine, Meinders, Arend-Jan, Byrne, Stephen, Kearney, Patricia M, O'Mahony, Denis, Knol, Wilma, Boland, Benoît, Gencer, Baris, Aujesky, Drahomir, Rodondi, Nicolas, MS Geriatrie, Baretella, Oliver, Alwan, Heba, Feller, Martin, Aubert, Carole E, Del Giovane, Cinzia, Papazoglou, Dimitrios, Christiaens, Antoine, Meinders, Arend-Jan, Byrne, Stephen, Kearney, Patricia M, O'Mahony, Denis, Knol, Wilma, Boland, Benoît, Gencer, Baris, Aujesky, Drahomir, and Rodondi, Nicolas

Published
2023

36. Greek Remdesivir Cohort (GREC) Study: Effectiveness of Antiviral Drug Remdesivir in Hospitalized Patients with COVID-19 Pneumonia

Author

Petrakis, Vasilis, primary, Rapti, Vasiliki, additional, Akinosoglou, Karolina, additional, Bonelis, Constantinos, additional, Athanasiou, Kalomoira, additional, Dimakopoulou, Vasiliki, additional, Syrigos, Nikolaos K., additional, Spernovasilis, Nikolaos, additional, Trypsianis, Grigoris, additional, Marangos, Markos, additional, Gogos, Charalambos, additional, Papazoglou, Dimitrios, additional, Panagopoulos, Periklis, additional, and Poulakou, Garyfallia, additional

Published
2022
Full Text
View/download PDF

37. Remission of refractory Crohn's disease with anti‐IL‐12/23 therapy in a patient undergoing hemodialysis: A case report.

Author

Spathakis, Michail, Filidou, Eirini, Kolios, George, Papazoglou, Dimitrios, and Vradelis, Stergios

Subjects
CROHN'S disease, DISEASE remission, HEMODIALYSIS patients, CHRONIC kidney failure, DISEASE relapse, RECEPTOR antibodies
Abstract

Crohn's disease is a relapsing chronic inflammatory condition of the intestine with increasing prevalence around the world. Biologic therapies are currently widely used and have proved safe and effective in treating moderate to severe Crohn's disease. However, contemporary bibliography contains little information about the use of these drugs in patients with end‐stage renal disease undergoing hemodialysis. Here we present a case of a 47‐year‐old female patient with treatment‐refractory Crohn's disease on hemodialysis. In this patient, treatment with the anti‐IL‐12/23 receptor antibody ustekinumab was effective in inducing and maintaining remission while being safe in administering throughout hemodialysis. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

41. SARSCOV-2 PSYCHOSOMATIC EFFECTS AND FEAR OF STIGMA ON THE DISCHARGE DAY OF INFECTED INDIVIDUALS: SAPFO STUDY

Author

Panagopoulos Periklis, Petrakis Vasilis, Penlioglou Theano, Kapetanidou Elli, and Papazoglou Dimitrios

Subjects
Adult, Male, medicine.medical_specialty, medicine.medical_treatment, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Oxygen therapy, medicine, Humans, Effective treatment, General hospital, Psychiatry, SARS-CoV-2, business.industry, COVID-19, Fear, General Medicine, Patient Discharge, SARS-COV-2 infection, CoVID-19, stigma, fear, psychosomatic effects, Stigma (anatomy), Psychiatry and Mental health, Distress, Quality of Life, Anxiety, Female, medicine.symptom, business, Psychosocial
Abstract

Background Although research has been mainly focused on effective treatment for SARS-COV-2 infection, psychosocial aspects of the infection it is vital to be taken into consideration. The aim of the present study is to evaluate the psychosomatic effects and the fear of stigma which patients may face after the end of treatment and discharge from hospital. Subjects and methods This was a non-intervention perspective study conducted in the Department of Infectious Diseases of University General Hospital of Alexandroupolis (Greece). Patients on the discharge day completed questionnaires in which 5 topics were evaluated: pain/discomfort, anxiety/distress, fear/worries, stigma and tolerance of treatment. The questionnaires were derived from similar Quality of Life Tools. The total score of each patient was normalized as percentage. Results Females and younger than 40 years old had more worries and fears on discharge day. Significant factors were days of hospitalization, days of fever and need of oxygen therapy. Patients who hospitalized more than 10 days, particularly in isolation negative pressure rooms, with persistent fever more than 7 days and need of oxygen therapy had more anxiety, worries for their clinical condition and fear of stigma. The majority of patients (80%) were expecting to face moderate to severe problems with family members, friends and colleagues underlying the dimensions of stigma. Conclusions It is crucial to evaluate the psychosocial aspects of this infection and limit the stigma which patients may face returning to their daily routine. Further studies are needed with larger patient series and with the usage of psychometric instruments.

Published
2020

47. Ofeleein i mi Vlaptin—Volume II: Immunity Following Infection or mRNA Vaccination, Drug Therapies and Non-Pharmacological Management at Post-Two Years SARS-CoV-2 Pandemic

Author

Kountouras, Jannis, primary, Gialamprinou, Dimitra, additional, Kotronis, Georgios, additional, Papaefthymiou, Apostolis, additional, Economidou, Eleftheria, additional, Soteriades, Elpidoforos S., additional, Vardaka, Elisabeth, additional, Chatzopoulos, Dimitrios, additional, Tzitiridou-Chatzopoulou, Maria, additional, Papazoglou, Dimitrios David, additional, and Doulberis, Michael, additional

Published
2022
Full Text
View/download PDF

49. Lysophospholipid Metabolism and Signalling in Non-Alcoholic Fatty Liver Disease

Author

Papadopoulos, Charalambos, Tentes, Ioannis, Papazoglou, Dimitrios, and Anagnostopoulos, Konstantinos

Subjects
lysophosphatidylcholine, nutritional and metabolic diseases, non-alcoholic fatty liver disease, lipids (amino acids, peptides, and proteins), digestive system, digestive system diseases, lysophosphatidic acid, sphingosine 1-phosphate, lysophospholipids
Abstract

Non-alcoholic liver disease (NAFLD) constitutes a global health pandemic. It is estimated that about 25% of the world’s population suffers from NAFLD. In the long-term, a subgroup of the patients can develop inflammation and fibrosis. The end result in some cases is cirrhosis and even liver-related death. The epidemiology and natural history of NAFLD lead to extreme financial costs. To date, there is no approved treatment for NAFLD. Lipotoxicity has been proposed to be one of the main regulators of the implicated molecular pathomechanisms. Research has been focused on the role of cholesterol, free fatty acids and ceramides. Nevertheless, lysophospholipids, such as sphingosine 1-phosphate (S1P), lysophosphatidylcholine (LPC), lysophosphatidic acid (LPA), lysophosphatidylinositol (LPI), lysophosphatidylethanolamine (LPE) have emerged as potential contributors to NAFLD/NASH. Finally, the metabolism of other lysophospholipids, such as lysophosphatidylserine (LPSer), lysophosphatidylglycerol (LPG), and lysocardiolipin (LCL), has come to light in the context of NAFLD. In this review, we try to summarize the current knowledge regarding the potential of lysophospholipid signalling and metabolism as therapeutic targets and biomarkers in NAFLD and/or NASH.

Published
2022

50. Cutaneous Manifestations in Patients with SARS- CoV-2 Infections

Author

Petrakis, Vasilios, Panagopoulos, Periklis, Terzi, Irene, and Papazoglou, Dimitrios

Subjects
COVID-19, SARS-CoV-2, skin lesions, cutaneous manifestations
Abstract

While SARS-CoV-2 is known to cause pneumonia and acute respiratory distress syndrome (ARDS), many extrapulmonary manifesta- tions of COVID-19 have also been observed. Cutaneous manifestations including erythematous rash, urticaria, and chickenpox-like vesicles have been described in patients with SARS-CoV-2. Six patients, two men and four women, in the age group of 50 to 60 years old, hospitalized with SARS-CoV-2 infection confirmed with real-time polymerase chain reac- tion (real-time PCR) presented cutaneous manifestations. The rash was confluent, spotty, centrifugal, and non-itchy on the head and torso. It was not hemorrhagic, and no crust or blisters were observed. The results of laboratory tests were normal, and the rash disappeared on its own. Sev- eral cases of cutaneous manifestations have been reported in patients with SARS-CoV-2 infection. Further studies are needed in order to assess the skin lesions and determine their association with COVID-19.

Published
2022

Catalog

Books, media, physical & digital resources
See catalog results